Department of Clinical Sciences and Services, Royal Veterinary College (University of London), Hawkshead Campus North Mymms, Hatfield AL9 7TA, United Kingdom.
Advanced Veterinary Therapeutics, Newtown, NSW 2042, Australia.
Microbiol Spectr. 2018 May;6(3). doi: 10.1128/microbiolspec.ARBA-0023-2017.
While antimicrobial resistance is already a public health crisis in human medicine, therapeutic failure in veterinary medicine due to antimicrobial resistance remains relatively uncommon. However, there are many pathways by which antimicrobial resistance determinants can travel between animals and humans: by close contact, through the food chain, or indirectly via the environment. Antimicrobial stewardship describes measures that can help mitigate the public health crisis and preserve the effectiveness of available antimicrobial agents. Antimicrobial stewardship programs have been principally developed, implemented, and studied in human hospitals but are beginning to be adapted for other applications in human medicine. Key learning from the experiences of antimicrobial stewardship programs in human medicine are summarized in this article-guiding the development of a stewardship framework suitable for adaptation and use in both companion animal and livestock practice. The antimicrobial stewardship program for veterinary use integrates infection prevention and control together with approaches emphasizing avoidance of antimicrobial agents. The 5R framework of continuous improvement that is described recognizes the importance of executive support; highly motivated organizations and teams (responsibility); the need to review the starting position, set objectives, and determine means of measuring progress and success; and a critical focus on reducing, replacing, and refining the use of antimicrobial agents. Significant issues that are currently the focus of intensive research include improved detection and diagnosis of infections, refined dosing regimens that are simultaneously effective while not selecting resistance, searches for alternatives to antimicrobial agents, and development of improved vaccines to enhance immunity and reduce disease.
虽然抗菌药物耐药性已经成为人类医学中的公共卫生危机,但由于抗菌药物耐药性而导致兽医治疗失败的情况仍然相对较少。然而,有许多途径可以使抗菌药物耐药性决定因素在动物和人类之间传播:通过密切接触、通过食物链,或间接通过环境。抗菌药物管理描述了有助于减轻公共卫生危机和保留现有抗菌药物效力的措施。抗菌药物管理计划主要在人类医院中开发、实施和研究,但现在开始适应人类医学中的其他应用。本文总结了从人类医学中抗菌药物管理计划的经验中获得的关键知识,为适合在伴侣动物和家畜实践中改编和使用的管理框架的制定提供了指导。兽医抗菌药物管理计划将感染预防和控制与强调避免使用抗菌药物的方法相结合。所描述的持续改进的 5R 框架认识到行政支持的重要性;高度积极的组织和团队(责任);需要审查起点、设定目标以及确定衡量进展和成功的方法;并严格关注减少、替代和改进抗菌药物的使用。目前正在深入研究的重大问题包括改进感染的检测和诊断、同时有效且不选择耐药性的精细剂量方案、寻找抗菌药物替代品以及开发改良疫苗以增强免疫力和减少疾病。